[Microdosing with psychedelics: what do we know?]

CONCLUSION: The findings of experimental studies in combination with the reports from users give cause for further investigation into the clinical potential of low-dose psychedelics in combating certain symptoms. More placebo-controlled studies are needed to provide clarity for who (age, diagnosis) md can be effective and for which (cognitive, emotional) processes. PMID: 32816295 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32816295?dopt=Abstract

Source: Tijdschrift voor Psychiatrie - August 22, 2020 Category: Psychiatry Authors: Kuypers KPC Tags: Tijdschr Psychiatr Source Type: research